COMP <GO>
SRTA vs UNH // ENTERPRISE SCALE & MARKET CAP
Strata Critical Medical Inc. (Class A) (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: SRTA 4
— UNH 8
▲ ENTERPRISE SCALE & MARKET CAP LEADER: UNH
LAST: $4.75 (-0.21%) • MKT CAP: $420.2M
market-cap
$420.2M
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
market-cap
$368.83B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SRTA VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SRTA | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 20.90% | 88.57% | -67.67 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -7.10% | 11.47% | -18.57 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -13.92% | 6.48% | -20.40 | UNH | /fcf-yield <GO> |
| Operating Margin | -11.30% | 4.82% | -16.12 | UNH | /operating-margins <GO> |
| Net Profit Margin | 21.00% | 3.14% | +17.86 | SRTA | /net-margins <GO> |
| Revenue Growth (YoY) | 34.30% | 6.46% | +27.84 | SRTA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.58 | 3.12 | +2.46 | SRTA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 36.4 | 59.2 | -22.79 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 8.6x | 17.1x | -8.49 | SRTA | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $420.2M | $368.83B | -$368.41B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SRTA REV | UNH REV | SRTA GROSS % | UNH GROSS % | SRTA FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $197.1M | $447.57B | 20.9% | 88.7% | -$58.5M | $16.07B |
| FY 2024 | $146.8M | $400.28B | 20.2% | 88.3% | -$33.4M | $20.70B |
| FY 2023 | $225.2M | $371.62B | — | 89.6% | -$32.3M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SRTA // BETA —
UNH // BETA 0.33